Table 2.
Characteristics | Disease-free survival rate (%) | 5-year survival rate (%) | ||||
---|---|---|---|---|---|---|
KAI1/CD82 + | KAI1/CD82 − | P value | KAI1/CD82 + | KAI1/CD82 − | P value | |
Age at surgery (years) | ||||||
≤50 | 64.3 | 54.6 | 0.8587 | 87.1 | 93.2 | 0.5449 |
>50 | 92.9 | 25.7 | 0.0005 | 96.2 | 81.4 | 0.0860 |
ER status | ||||||
+ | 94.4 | 39.6 | 0.0207 | 100.0 | 94.4 | >0.9999 |
− | 70.7 | 40.8 | 0.0719 | 87.8 | 78.2 | 0.2174 |
Tumor status | ||||||
T1 | 75.0 | 67.3 | 0.0226 | 100.0 | 100.0 | >0.9999 |
T2 | 90.9 | 35.7 | 0.0105 | 95.0 | 84.4 | 0.2012 |
T3 | 57.1 | 50.0 | 0.6415 | 83.3 | 66.7 | 0.5637 |
T4 | 0.0 | 33.3 | 0.5151 | 0.0 | 66.7 | 0.0833 |
Nodal status | ||||||
N0 | 95.7 | 54.1 | 0.0243 | 95.2 | 93.3 | 0.8570 |
N1 | 72.9 | 27.5 | 0.0729 | 94.4 | 85.5 | 0.3488 |
N2 | 33.3 | 20.0 | 0.3727 | 66.7 | 33.3 | 0.9883 |
Pathological stage | ||||||
I | 100.0 | 70.1 | 0.0429 | 100.0 | 100.0 | >0.9999 |
II | 83.6 | 36.6 | 0.0108 | 92.3 | 86.8 | 0.3911 |
III | 42.9 | 33.3 | 0.5373 | 85.7 | 71.4 | 0.6945 |
Total number of patients | 80.2 | 38.2 | 0.0065 | 92.8 | 87.0 | 0.3080 |